Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Dermatologic Therapy|May 22, 2021
Fractional CO<sub>2</sub> laser to improve noticeable scars after skin cancer surgery: An appraisal by the patients, laypersons, and expertsNina Wyss, Nicole Graf, Juerg Hafner, et al.Antioxidants (Basel, Switzerland)|August 26, 2022
Vitamin C Deficiency in Blood Samples of COVID-19 PatientsTobias Sinnberg, Christa Lichtensteiger, Katharina Hill-Mündel, et al.Journal for Immunotherapy of Cancer|March 16, 2022
C reactive protein flare predicts response to checkpoint inhibitor treatment in non-small cell lung cancerNiklas Klümper, Jonas Saal, Fiamma Berner, et al.Melanoma Research|April 23, 2025
Open-label nonrandomized phase IB study to characterize the safety and recommended dose of tinostamustine in combination with nivolumab in patients with advanced melanoma (ENIgMA)Markus Joerger, Stefan Diem, Nina Wyss, et al.Nature Cancer|July 31, 2023
Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanomaRenáta Váraljai, Lisa Zimmer, Yahya Al-Matary, et al.Science Immunology|September 2, 2022
Autoreactive napsin A-specific T cells are enriched in lung tumors and inflammatory lung lesions during immune checkpoint blockadeFiamma Berner, David Bomze, Christa Lichtensteiger, et al.Med (New York, N.Y.)|January 24, 2023
Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitorsNicolas Gonzalo Nuñez, Fiamma Berner, Ekaterina Friebel, et al.American Journal of Respiratory and Critical Care Medicine|April 16, 2024
Autoimmunity Against Surfactant Protein B Is Associated with Pneumonitis During Checkpoint BlockadeNina Wyss, Fiamma Berner, Vincent Walter, et al.American Journal of Respiratory and Critical Care Medicine|August 4, 2022
Pulmonary Surfactant Proteins Are Inhibited by Immunoglobulin A Autoantibodies in Severe COVID-19Tobias Sinnberg, Christa Lichtensteiger, Omar Hasan Ali, et al.Pageof 1